Garcia-Rostan, G., Camp, R. L., Herrero, A., Carcangiu, M. L., Rimm, D. L., & Tallini, G. (2001). β-Catenin Dysregulation in Thyroid Neoplasms: Down-Regulation, Aberrant Nuclear Expression, and CTNNB1 Exon 3 Mutations Are Markers for Aggressive Tumor Phenotypes and Poor Prognosis. American Society for Investigative Pathology.

Garcia-Rostan, Ginesa, Robert L. Camp, Agustin Herrero, Maria Luisa Carcangiu, David L. Rimm, e Giovanni Tallini. β-Catenin Dysregulation in Thyroid Neoplasms: Down-Regulation, Aberrant Nuclear Expression, and CTNNB1 Exon 3 Mutations Are Markers for Aggressive Tumor Phenotypes and Poor Prognosis. American Society for Investigative Pathology, 2001.

Garcia-Rostan, Ginesa, et al. β-Catenin Dysregulation in Thyroid Neoplasms: Down-Regulation, Aberrant Nuclear Expression, and CTNNB1 Exon 3 Mutations Are Markers for Aggressive Tumor Phenotypes and Poor Prognosis. American Society for Investigative Pathology, 2001.